CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL — image 1 of 2

Product details

CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL

Catalog number BNC882345-100

Price for BNC882345-100

Size / count 1x 100 µL

About this product

This antibody recognizes an epitope encoded by exon v4 on the variant portion of human CD44. The CD44 molecule belongs to a family of cellular adhesion molecules found on a wide range of normal and malignant cells in epithelial, mesothelial and hemopoiesis tissues. CD44 is a single gene with 20 exons, of which 10 are normally expressed to encode the basic CD44 (H-CAM) molecule. The additional 10 exons (v1 to v10) are only expressed by alternative splicing of the nuclear RNA. The expression of specific cell adhesion molecule CD44 splice variants has been reported to be associated with metastasis in certain human malignancies.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC882345-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: LHR; BA-1; chondroitin sulfate proteoglycan 8 (CSPG8) ; Epican; Extracellular Matrix Receptor III (ECM III) ; GP90 Lymphocyte Homing Adhesion Receptor; HCAM; HCELL; hematopoietic cell E- and L-selectin ligand; Heparan Sulfate Proteoglycan; Hermes Antigen; HAS; HUTCH I; Hyaluronate Receptor; Indian blood group; Inlu Related p80 Glycoprotein; Ly 24; MDU2; MDU3; MIC4; MUTCH I; Phagocytic Glycoprotein 1 (PGP-1)
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: CD44
Gene ID: 960
NCBI Gene ID: 502328
UniProt: P16070
Swiss Prot: P16070
Host: Mouse
Species Reactivity: Human
Reactivity: CD44v9
Immunogen: Recombinant fragment corresponding to the v9 domain of human CD44
Target Antigen: CD44v9
Clonality: Recombinant Monoclonal
Clone: RCD44v9/1459
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Cancer, Immunology
Positive Control: Cervix or Tongue Squamous Cell Carcinoma
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 80-95 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF488A

Frequently Asked Questions

What is the catalog number for CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL?

The catalog number for CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL is BNC882345-100.

What sizes are available for CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL?

CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL in stock?

CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL?

CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL?

Estimated delivery time for CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL?

The safety data sheet for CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is CD44v9 (Marker of Tumor Metastasis) (rCD44v9/1459), CF488A conjugate, 0.1mg/mL used for?

Does this product need any special customs documentation to be imported to my country?

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

What buffer is this product supplied in?

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.